Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer
CA: A Cancer Journal for Clinicians · 2026-03 · 76 (2)
DOI: 10.3322/caac.70077 ↗Kurz gefasst
Fachartikel in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 20.04.2026. Verfasst von Carrie Printz.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Printz, C. (2026). Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer. CA: A Cancer Journal for Clinicians, 76(2). https://doi.org/10.3322/caac.70077
Vancouver
Printz C. Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer. CA: A Cancer Journal for Clinicians. 2026;76(2). doi:10.3322/caac.70077
BibTeX
@article{Printz2026,
author = {Printz, Carrie},
title = {Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer},
journal = {CA: A Cancer Journal for Clinicians},
year = {2026},
volume = {76},
number = {2},
doi = {10.3322/caac.70077}
}
EUVIMED